A Novel Classifier Based on Urinary Proteomics for Distinguishing Between Benign and Malignant Ovarian Tumors

BACKGROUND: Preoperative differentiation of benign and malignant tumor types is critical for providing individualized treatment interventions to improve prognosis of patients with ovarian cancer. High-throughput proteomics analysis of urine samples was performed to identify reliable and non-invasive...

Descripción completa

Detalles Bibliográficos
Autores principales: Ni, Maowei, Zhou, Jie, Zhu, Zhihui, Yuan, Jingtao, Gong, Wangang, Zhu, Jianqing, Zheng, Zhiguo, Zhao, Huajun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Cell and Developmental Biology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8437375/
https://www.ncbi.nlm.nih.gov/pubmed/34527671
http://dx.doi.org/10.3389/fcell.2021.712196

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8437375/
https://www.ncbi.nlm.nih.gov/pubmed/34527671
http://dx.doi.org/10.3389/fcell.2021.712196

Ejemplares similares